No. of Pages: 168 | Report Code: TIPRE00024254 | Category: Life Sciences
聚合酶链式反应 (PCR) 用于准确的护理诊断，有助于快速识别和确定呼吸道感染的原因。此外，PCR 在住院和门诊环境中受到广泛青睐，有助于促进近年来市场的增长。
南美洲和中美洲呼吸道感染诊断PCR市场预计到2028年将达到5.0255亿美元2021 年为 2.6255 亿美元；预计 2021 年至 2028 年复合年增长率为 9.7%。市场的增长是由一些关键驱动因素决定的，例如慢性呼吸道疾病 (CRD) 负担的增加和 PCR 检测的不断发展，预计将推动市场的增长。然而，替代检测的可用性是阻碍市场增长的主要因素。
由于烟草的大量消费，慢性呼吸道疾病 (CRD) 是全球发病的主要原因之一。例如，根据世界卫生组织的数据，2018 年美国第四大死因是慢性下呼吸道疾病，主要是慢性阻塞性肺病。近 1570 万美国人 (6.4%) 被诊断患有慢性阻塞性肺病。由于空气质量差、吸烟成瘾增加以及更容易患慢性阻塞性肺病和肺癌的老年人口增加，预计未来慢性呼吸道疾病的负担将会增加。此外，各国发起的旨在改善治疗和支持呼吸道疾病患者的计划可能会增加对呼吸道疾病诊断的 PCR 的需求。这将导致预测期内的市场增长。过去几年，用于诊断传染病的 PCR 检测的需求显着增加。不断发展的技术进步增加了通过 PCR 进行即时检测的额外优势，从而增加了对 PCR 诊断的需求。此外，由于 COVID-19 的爆发，需求呈指数级增长。自疫情爆发以来，逆转录聚合酶反应（RT-PCR）测试已被优先用于诊断和检查 SARS-CoV-2 RNA 的遗传物质。 RT-PCR 方法因其检测灵敏而被广泛接受为检测 SARS-CoV-2 RNA 的金标准。因此，考虑到PCR检测的需求，各市场参与者纷纷推出PCR产品，进入全球市场的战略发展。此外，大多数公司现在都提供针对 COVID-19 的实时聚合酶链反应 (PCR) 测试，这有助于目标市场的增长。
COVID- 19日疫情对巴西、阿根廷等国造成严重影响。由于对通过 PCR 进行 COVID-19 检测的巨大需求，市场在大流行期间经历了指数级增长。 COVID-19 发病率的增加增加了对 PCR 检测的需求，这为市场带来了重要的增长机会。巴西还建立了公私合作伙伴关系，以加强 PCR 检测试剂盒和产品的生产。因此，由于各国 PCR 检测数量众多，估计用于呼吸道感染诊断的 PCR 检测已引起广泛关注，并在该地区获得了巨大的市场规模。由于各国政府的不断发展和政府努力增加 PCR 检测，预计该市场在预测期内将蓬勃发展。
< p>
根据类型，南美洲和中美洲呼吸道感染诊断 PCR 市场细分为实时 PCR (qPCR)、传统 PCR、逆转录酶 (RT-PCR)、数字 PCR、多重 PCR 等。实时 PCR (qPCR) 细分市场在 2021 年占据最大市场份额，预计在预测期内将实现最高的复合年增长率。
基于根据产品类型，南美洲和中美洲呼吸道感染诊断 PCR 市场分为试剂和试剂盒、仪器等。试剂和试剂盒细分市场在 2021 年占据最大市场份额，预计在预测期内复合年增长率最高。
根据感染类型，南美洲和中美洲呼吸道感染诊断市场的 PCR 分为细菌感染、病毒感染和真菌感染。其他病原体。 2021 年，病毒感染细分市场占据最大市场份额，预计在预测期内复合年增长率最高。
根据最终用户，南方市场中美洲呼吸道感染诊断 PCR 市场细分为医院、医生诊所、临床实验室、学术和研究机构、生物技术和制药公司等。 2020 年，临床实验室细分市场占据最大市场份额，预计在预测期内复合年增长率最高。
< /p>
一些主要和次要来源与这份关于南美洲和中美洲呼吸道感染诊断市场 PCR 的报告相关的机构包括国家医疗服务体系 (NHS)、世界卫生组织 (WHO) 和疾病控制与预防中心 (CDC)。
< p>
Strategic insights for South and Central America PCR for Respiratory Infection Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 262.55 Million |
| Market Size by 2028 | US$ 502.55 Million |
| Global CAGR (2021 - 2028) | 9.7% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 南美洲和中美洲
|
| Market leaders and key company profiles |
The regional scope of South and Central America PCR for Respiratory Infection Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South and Central America PCR for Respiratory Infection Diagnostics Market is valued at US$ 262.55 Million in 2021, it is projected to reach US$ 502.55 Million by 2028.
As per our report South and Central America PCR for Respiratory Infection Diagnostics Market, the market size is valued at US$ 262.55 Million in 2021, projecting it to reach US$ 502.55 Million by 2028. This translates to a CAGR of approximately 9.7% during the forecast period.
The South and Central America PCR for Respiratory Infection Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America PCR for Respiratory Infection Diagnostics Market report:
The South and Central America PCR for Respiratory Infection Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America PCR for Respiratory Infection Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America PCR for Respiratory Infection Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South and Central America PCR for Respiratory Infection Diagnostics Market
